UBS AM’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.19M | Buy |
146,322
+32,867
| +29% | +$1.17M | ﹤0.01% | 1689 |
|
2025
Q1 | $3.85M | Sell |
113,455
-22,983
| -17% | -$780K | ﹤0.01% | 1696 |
|
2024
Q4 | $4.44M | Buy |
136,438
+36,181
| +36% | +$1.18M | ﹤0.01% | 1665 |
|
2024
Q3 | $4.89M | Sell |
100,257
-6,276
| -6% | -$306K | ﹤0.01% | 1581 |
|
2024
Q2 | $4.72M | Sell |
106,533
-223,790
| -68% | -$9.91M | ﹤0.01% | 1524 |
|
2024
Q1 | $18.5M | Buy |
330,323
+29,917
| +10% | +$1.68M | 0.01% | 809 |
|
2023
Q4 | $18.1M | Buy |
300,406
+38,001
| +14% | +$2.29M | 0.01% | 794 |
|
2023
Q3 | $17.6M | Buy |
262,405
+47,947
| +22% | +$3.22M | 0.01% | 789 |
|
2023
Q2 | $10.3M | Hold |
214,458
| – | – | 0.01% | 963 |
|
2023
Q1 | $10.3M | Buy |
214,458
+31,961
| +18% | +$1.54M | 0.01% | 963 |
|
2022
Q4 | $9.11M | Sell |
182,497
-312,379
| -63% | -$15.6M | ﹤0.01% | 977 |
|
2022
Q3 | $20.2M | Buy |
494,876
+9,737
| +2% | +$397K | 0.01% | 762 |
|
2022
Q2 | $26.7M | Buy |
485,139
+320,007
| +194% | +$17.6M | 0.01% | 674 |
|
2022
Q1 | $6M | Buy |
165,132
+44,798
| +37% | +$1.63M | ﹤0.01% | 1277 |
|
2021
Q4 | $5.61M | Buy |
+120,334
| New | +$5.61M | ﹤0.01% | 1362 |
|
2020
Q3 | – | Sell |
-25,000
| Closed | -$1.06M | – | 2501 |
|
2020
Q2 | $1.06M | Buy |
+25,000
| New | +$1.06M | ﹤0.01% | 1775 |
|